However, it should be noted that time is an essential component for expected results, as internal systems take a rather long time to respond, and feed supplement results tend to be visible upon consistent application
Zhan J, Cao H, Hu T, Shen J, Wang W, Wu P
The Journal of clinical investigation 123 , 43094317, doi:10.1172/JCI64801 (2013)
Defining the correlation between immune-checkpoint inhibitors-related adverse events and clinical outcomes: a narrative review Omar Abdihamid 1 , Abeid Omar 2 and Tibera Rugambwa 3 1 Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, Peoples Republic of China 2 Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria University, Champlion Street, Alazarita, Alexandria 21131, Egypt 3 Department of Internal Medicine, Mbeya Zonal Referral Hospital, Mbeya 419, Tanzania Abstract Immune checkpoint inhibitors (ICIs) have increased modern anticancer armamentarium portfolios, with 15%60% of cancer patients deriving clinical benefit while others progress, including some occurrences of accelerated progressions
El rango ptimo generalmente aceptado es 0.1-0.3% (1,000-3,000 ppm) aplicado 1-2 veces/da sobre piel limpia